![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 2013 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Heidelberg, DE HQ |
Employees | Employees 11914% increase | Employees 76 |
Financial | ||
Net income | Net income ($176.6m) (FY, 2021) | Net income (€105.9m) (FY, 2023) |

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company